Journal Alimentary Pharmacology & Therapeutics
Researchers assessed the cost effectiveness of mass screening for celiac disease determined by time-delay to diagnosis and quality of life on a gluten-free diet. Their model suggests that mass screening for celiac disease of the young-adult general population is associated with improved QALYs and is a cost effectiveness strategy. Shortening of the time-delay to diagnosis by heightened awareness of health-care professionals may be a valid alternative to screening.
Bonnie - yes! yes! yes!
No comments:
Post a Comment